The global throat sprays market is expected to reach a valuation of US$ 484.0 million in 2023. Sales of throat sprays are expected to gain traction at a 2.1% CAGR over the forecast period, with the market size reaching US$ 598.3 million by 2033.
One of the primary causes of many respiratory diseases is believed to be rising levels of air pollution and the spread of infections in urban areas. Particulate matter exposure can irritate the throat and induce soreness, which ranges from slight discomfort to severe discomfort.
Throat infections are more common now because of environmental changes, pollution, and air contamination. Manufacturers of throat sprays place a strong emphasis on new product introductions and ongoing innovation using organic ingredients and herbs.
Sales of throat sprays are expected to increase globally, as most throat sprays are over-the-counter (OTC) medicines that do not require a prescription from a doctor. Because customers are conditioned to treat common illnesses like colds, coughs, and sore throats at home rather than seeing a doctor, demand for throat sprays is likely to increase.
The market value for throat sprays was approximately 1.5% of the overall US$ 32.0 billion of the global cold, cough & sore throat remedies market in 2021.
What are the Key Opportunities for Throat Sprays Manufacturers?
High Demand for Affordable Throat Sprays Across Emerging Economies is likely to Fuel Sales
Companies benefit from an increase in global market consolidation activities like mergers and acquisitions, partnerships, and collaboration. Offering well-known cough and cold remedies at affordable pricing is likely to aid in improving sales.
Significant growth prospects for the throat sprays market are anticipated across emerging economies thanks to increased promotional and awareness campaigns and improved healthcare access. These factors cumulatively present lucrative opportunities for growth in the throat sprays sector throughout the forecast period.
Which Factors are Restraining Demand for Throat Sprays?
One of the main barriers preventing the widespread use of specific drugs is medication errors or overdosing. The patient's health negatively be impacted by side effects from overdoses or drug resistance.
For example, sprays sold under different names, such as Hurricane, Topex, and Cetacaine, are frequently used to assist the placement of nasogastric tubes for small procedures. Such anesthetic sprays have the potential to lead to addiction and overdose.
The FDA has issued a warning that certain documented cases of methemoglobinemia have been linked to medication errors because of improper benzocaine spray usage (e.g., longer duration or more frequent sprays than recommended).
Medication errors have a negative impact on a patient's health and hinder the use of the product, which can limit sales in the market. Additionally, the availability of alternatives is likely to limit the use of throat sprays because they are more readily available and more reasonably priced than throat sprays.
| Attributes | Details |
|---|---|
| Throat Sprays Market CAGR (2023 to 2033) | 2.1% |
| Throat Sprays Market Size (2023) | US$ 484 million |
| Throat Sprays Market Size (2033) | US$ 598.3 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of throat sprays are forecast to increase at a 2.1% CAGR over the assessment period, in comparison to the CAGR of 2.0% registered between 2018 to 2022, owing to the advent of the infections associated with the COVID-19 pandemic. Market valuation went up from US$ 437.38 million in 2018 to US$ 473.8 million in 2022.
Among the most prevalent illnesses in primary care are upper respiratory tract infections including laryngitis, pharyngitis, nasopharyngitis, and rhinitis. Symptoms include coughing, sore throat, nasal obstruction, and headache.
Even in the absence of treatment, acute sore throats are self-limiting and often go away in 3 to 7 days. However, the discomfort brought on by a sore throat can considerably affect daily activities and quality of life, and it continues to be one of the most frequent causes of primary care consultations.
With peak sales throughout the cold and flu season, sales of throat sprays are expected to gain traction. Ingredients in the formulation could be used to treat symptoms or stop the spread of a viral infection.
Throat sprays are a desirable delivery route for over-the-counter medications, such as sore throat remedies, due to the relatively low developmental barriers. Choosing a reliable and practical medication delivery system is vital to developing brand loyalty in the market.
In the European Union, oral/throat sprays are frequently endorsed as medical devices to prevent common colds. For example, the trypsin/glycerol mouth spray claims that it can shorten/reduce common cold symptoms, stop colds, and stop the host cell infection from the COVID-19 virus.
Topical delivery methods provide various benefits over systemic drug administration, including enhanced product bioavailability, decreased adverse and off-target effects, and greater patient convenience, which promotes compliance. For effective delivery of medications for pain relief, throat sprays are a preferred mode of administration to provide symptomatic relief to patients with common cold and associated infections of the throat.
Throat Sprays Market:
| Attributes | Throat Sprays Market |
|---|---|
| CAGR (2023 to 2033) | 2.1% |
| Market Value (2023) | US$ 598.3 million |
| Growth Factor | Focus on active delivery systems |
| Opportunity | Affordability in different countries |
| Trends | Promotional and awareness campaigns |
Strep Throat Treatment Market:
| Attributes | Strep Throat Treatment Market |
|---|---|
| CAGR (2023 to 2033) | 4.4% |
| Market Value (2023) | US$ 3,200 million |
| Growth Factor | Surging investment from foreign investors |
| Opportunity | Growing incidence of bacterial infections |
| Trends | Public awareness and campaigns automation |
Cold, Cough and Sore Throat Remedies Market:
| Attributes | Cold, Cough and Sore Throat Remedies Market |
|---|---|
| CAGR (2023 to 2033) | 0.6% |
| Market Value (2023) | US$ 37,930 million |
| Growth Factor | Rising prevalence of infectious disease |
| Opportunity | Rising government initiatives |
| Trends | Surging sales of oral drugs |
Principal Consultant
| Country | Market Share (2023) |
|---|---|
| United States | 34.7% |
| Germany | 6.1% |
| Japan | 5.0% |
| Australia | 1.5% |
Increasing Demand for Sore Throat Sprays is likely to Boost Sales
The United States dominated the North America throat sprays industry in 2022, holding 90.1% of the market share. As per FMI, the trend is expected to continue over the forecast period owing to numerous awareness campaigns aimed at reducing infectious diseases as well as the existence of various key throat sprays and lozenge manufacturers in the country.
Growing Sales of Antiseptic Throat Sprays in Germany is likely to Fuel Growth
Demand in the Germany market is set to increase at a 2.9% CAGR over the assessment period. Rising prevalence of throat infections, owing to environmental factors such as cold weather conditions is spurring demand for throat sprays. With a high prevalence of throat infections in the pediatric population, manufacturers are launching throat sprays for kids for pain relief.
Consumers in China are Preferring Throat Spray for Cough
China held approximately 53.2% of the East Asia throat sprays market share in 2021, and sales are projected to increase at a 1.9% CAGR over the assessment period. Manufacturers in China are developing herbal nasal and throat spray from longan extract for infections such as COVID-19, which has increased the adoption of herbal formulations for throat sprays.
Demand for Anaesthetic Throat Sprays is likely to Gain Traction
Based on spray type, sales of anesthetic throat sprays is likely to increase at a 2.4% CAGR by 2033. Initially, it held 29.5% of the total market share in 2022. The spray contains a local anesthetic with rapid onset of action. It delivers the spray directly to the area of pain for targeted pain relief, quickly relieving discomfort associated with a sore throat.
Sales of Pumps and Dispensers is likely to Remain High
Pumps and dispensers hold a revenue share of around 66.3% in 2022 and are expected to display gradual growth over the forecast period. Growing concerns about the environmental impact of aerosols is expected to fuel sales in this segment. Thus, sustainable products are increasingly preferred over traditional sprays.
Demand for Throat Sprays in Hospital Pharmacies is likely to Increase
Hospital pharmacies accounted for the leading share 33.4% in 2022, and the trend is expected to continue over the forecast period. The prevalence of chronic and infectious disorders is on the rise, which continue pushing sales in this segment over the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Battle of the Sprays: Competitors Vie for Dominance in the Throat Sprays Industry
Technology advancements, strategic partnerships, R&D spending, and research all contribute significantly to the market expansion for throat sprays. Instances of key developmental strategies by the industry players in the throat sprays market are:
The projected revenue of the market by 2033 is US$ 598.3 million.
The market CAGR for 2033 is projected to be 2.1%.
Vicks, Strepsils, and Chloraseptic. are the key market players.
The market is estimated to secure a valuation of US$ 484 million in 2023.
North America is growing fast due to the increasing prevalence of respiratory diseases.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Spray Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Spray Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Spray Type, 2023 to 2033 5.3.1. Anaesthetics Throat Sprays 5.3.2. Anti-inflammatory Throat Sprays 5.3.3. Pain Relief Throat Sprays 5.3.4. Anti-bacterial Throat Sprays 5.3.5. Natural Extract Throat Sprays 5.4. Y-o-Y Growth Trend Analysis By Spray Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Spray Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Closures 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Closures, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Closures, 2023 to 2033 6.3.1. Aerosol Sprays 6.3.2. Pump and Dispensers 6.4. Y-o-Y Growth Trend Analysis By Closures, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Closures, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Capacity, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Capacity, 2023 to 2033 7.3.1. 5 ml 7.3.2. 10-15 ml 7.3.3. 20-30 ml 7.3.4. >30 ml 7.4. Y-o-Y Growth Trend Analysis By Capacity, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Capacity, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033 8.3.1. Retail Store Chains 8.3.2. Drug Stores 8.3.3. Hospital Pharmacies 8.3.4. Online Pharmacies 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Spray Type 10.2.3. By Closures 10.2.4. By Capacity 10.2.5. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Spray Type 10.3.3. By Closures 10.3.4. By Capacity 10.3.5. By Distribution Channel 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Spray Type 11.2.3. By Closures 11.2.4. By Capacity 11.2.5. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Spray Type 11.3.3. By Closures 11.3.4. By Capacity 11.3.5. By Distribution Channel 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Spray Type 12.2.3. By Closures 12.2.4. By Capacity 12.2.5. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Spray Type 12.3.3. By Closures 12.3.4. By Capacity 12.3.5. By Distribution Channel 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Spray Type 13.2.3. By Closures 13.2.4. By Capacity 13.2.5. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Spray Type 13.3.3. By Closures 13.3.4. By Capacity 13.3.5. By Distribution Channel 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Spray Type 14.2.3. By Closures 14.2.4. By Capacity 14.2.5. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Spray Type 14.3.3. By Closures 14.3.4. By Capacity 14.3.5. By Distribution Channel 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Spray Type 15.2.3. By Closures 15.2.4. By Capacity 15.2.5. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Spray Type 15.3.3. By Closures 15.3.4. By Capacity 15.3.5. By Distribution Channel 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Spray Type 16.2.3. By Closures 16.2.4. By Capacity 16.2.5. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Spray Type 16.3.3. By Closures 16.3.4. By Capacity 16.3.5. By Distribution Channel 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Spray Type 17.1.2.2. By Closures 17.1.2.3. By Capacity 17.1.2.4. By Distribution Channel 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Spray Type 17.2.2.2. By Closures 17.2.2.3. By Capacity 17.2.2.4. By Distribution Channel 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Spray Type 17.3.2.2. By Closures 17.3.2.3. By Capacity 17.3.2.4. By Distribution Channel 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Spray Type 17.4.2.2. By Closures 17.4.2.3. By Capacity 17.4.2.4. By Distribution Channel 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Spray Type 17.5.2.2. By Closures 17.5.2.3. By Capacity 17.5.2.4. By Distribution Channel 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Spray Type 17.6.2.2. By Closures 17.6.2.3. By Capacity 17.6.2.4. By Distribution Channel 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Spray Type 17.7.2.2. By Closures 17.7.2.3. By Capacity 17.7.2.4. By Distribution Channel 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Spray Type 17.8.2.2. By Closures 17.8.2.3. By Capacity 17.8.2.4. By Distribution Channel 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Spray Type 17.9.2.2. By Closures 17.9.2.3. By Capacity 17.9.2.4. By Distribution Channel 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Spray Type 17.10.2.2. By Closures 17.10.2.3. By Capacity 17.10.2.4. By Distribution Channel 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Spray Type 17.11.2.2. By Closures 17.11.2.3. By Capacity 17.11.2.4. By Distribution Channel 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Spray Type 17.12.2.2. By Closures 17.12.2.3. By Capacity 17.12.2.4. By Distribution Channel 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Spray Type 17.13.2.2. By Closures 17.13.2.3. By Capacity 17.13.2.4. By Distribution Channel 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Spray Type 17.14.2.2. By Closures 17.14.2.3. By Capacity 17.14.2.4. By Distribution Channel 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Spray Type 17.15.2.2. By Closures 17.15.2.3. By Capacity 17.15.2.4. By Distribution Channel 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Spray Type 17.16.2.2. By Closures 17.16.2.3. By Capacity 17.16.2.4. By Distribution Channel 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Spray Type 17.17.2.2. By Closures 17.17.2.3. By Capacity 17.17.2.4. By Distribution Channel 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Spray Type 17.18.2.2. By Closures 17.18.2.3. By Capacity 17.18.2.4. By Distribution Channel 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Spray Type 17.19.2.2. By Closures 17.19.2.3. By Capacity 17.19.2.4. By Distribution Channel 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Spray Type 17.20.2.2. By Closures 17.20.2.3. By Capacity 17.20.2.4. By Distribution Channel 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Spray Type 17.21.2.2. By Closures 17.21.2.3. By Capacity 17.21.2.4. By Distribution Channel 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Spray Type 17.22.2.2. By Closures 17.22.2.3. By Capacity 17.22.2.4. By Distribution Channel 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Spray Type 17.23.2.2. By Closures 17.23.2.3. By Capacity 17.23.2.4. By Distribution Channel 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Spray Type 18.3.3. By Closures 18.3.4. By Capacity 18.3.5. By Distribution Channel 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Prestige Consumer Healthcare Inc. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. Reckitt Benckiser Group PLC. 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Purdue Pharma 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. Procter & Gamble 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. Cipla Limited 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. iNova Pharmaceuticals (Difflam) 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. Marinomed Biotech AG 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. Biocidin Botanicals 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. URSATEC GmbH 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. Martin & Pleasance 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 19.1.11. Mega We Care 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.11.5.2. Product Strategy 19.1.11.5.3. Channel Strategy 19.1.12. PFL Healthcare (Snoreeze) 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 19.1.12.5.2. Product Strategy 19.1.12.5.3. Channel Strategy 19.1.13. Zenta Healthcare Private Limited 19.1.13.1. Overview 19.1.13.2. Product Portfolio 19.1.13.3. Profitability by Market Segments 19.1.13.4. Sales Footprint 19.1.13.5. Strategy Overview 19.1.13.5.1. Marketing Strategy 19.1.13.5.2. Product Strategy 19.1.13.5.3. Channel Strategy 19.1.14. Puressentiel Laboratory 19.1.14.1. Overview 19.1.14.2. Product Portfolio 19.1.14.3. Profitability by Market Segments 19.1.14.4. Sales Footprint 19.1.14.5. Strategy Overview 19.1.14.5.1. Marketing Strategy 19.1.14.5.2. Product Strategy 19.1.14.5.3. Channel Strategy 19.1.15. Melcare Biomedical 19.1.15.1. Overview 19.1.15.2. Product Portfolio 19.1.15.3. Profitability by Market Segments 19.1.15.4. Sales Footprint 19.1.15.5. Strategy Overview 19.1.15.5.1. Marketing Strategy 19.1.15.5.2. Product Strategy 19.1.15.5.3. Channel Strategy 19.1.16. Laboratoire Les 3 CHÊNES 19.1.16.1. Overview 19.1.16.2. Product Portfolio 19.1.16.3. Profitability by Market Segments 19.1.16.4. Sales Footprint 19.1.16.5. Strategy Overview 19.1.16.5.1. Marketing Strategy 19.1.16.5.2. Product Strategy 19.1.16.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Throat Sprays Market
